Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Thyroid Neoplasms 4Hypothyroidism 3Medulloblastoma 2Breast Neoplasms 2Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Neoplasms 1Head and Neck Neoplasms 1Goiter 1Gliosarcoma 1Glioblastoma 1Ependymoma 1Brain Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Triiodothyronine × Clear all
NCT03787303 2022-05-13

B-TREUH

Aultman Health Foundation

Phase 2 Terminated
7 enrolled 14 charts
Breast

Breast Neoplasms

NCT01360177 2016-07-20

Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers

Stanford University

Phase NA Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡